Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of amylmetacresol and 2,4-dichlorobenzyl alcohol lozenges for sore throat relief
2008-005059-67Phase 3Completed
- Sponsor
- Reckitt
- Start
- Oct 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in upper respiratory infection (URI) comparing Amylmetacresol lozenge, 2,4-Dichlorobenzyl alcohol lozenge and Placebo lozenge (3 arms). Primary endpoint: Area under the change-from-baseline curve in throat soreness from 0 to 2 hours. Started Oct 2008; status: completed.
02
Drugs
amylmetacresol2,4-dichlorobenzyl alcohol
03
Conditions
upper respiratory infection (URI)
Beyond the preview
Go deeper on 2008-005059-67.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005059-67.